X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/30/2920867/0/en/BioCardia-Submits-for-FDA-Approval-of-Morph-DNA-Steerable-Introducer-Product-Family.html
https://www.globenewswire.com/news-release/2024/07/25/2918703/0/en/Patient-Enrollment-Commenced-in-Pivotal-Phase-3-Trial-of-CardiAMP-Cell-Therapy-for-the-Treatment-of-Ischemic-Heart-Failure.html
https://www.globenewswire.com/news-release/2024/07/17/2914419/0/en/BioCardia-Announces-United-States-Patent-Issuance-on-Morph-DNA-Multi-Directional-Steerable-Catheter-Transseptal-Application.html
https://www.globenewswire.com/news-release/2024/07/08/2909505/0/en/CellProthera-and-BioCardia-Collaborate-on-Successful-Phase-II-Trial-of-ProtheraCytes-for-the-Treatment-of-Acute-Myocardial-Infarction.html
https://www.globenewswire.com/news-release/2024/06/07/2895288/0/en/BioCardia-Announces-United-States-Patent-Issuance-on-Intramyocardial-Delivery-of-Cell-Aggregates-to-the-Heart-Including-Minimally-Invasive-Radial-Artery-Approach.html
https://www.globenewswire.com/news-release/2024/05/21/2886074/0/en/BioCardia-Announces-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2024/05/14/2881844/0/en/BioCardia-Reports-First-Quarter-2024-Business-Highlights-and-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/09/2878594/0/en/BioCardia-to-Host-Q1-2024-Financial-Results-and-Corporate-Update-Conference-Call-on-May-14-2024.html
https://www.globenewswire.com/news-release/2024/05/01/2873082/0/en/BioCardia-s-CardiAMP-Cell-Therapy-Chronic-Myocardial-Ischemia-Trial-Results-Show-Patient-Benefits-in-Important-Outcomes.html
https://www.globenewswire.com/news-release/2024/04/25/2869697/0/en/BioCardia-Completes-Enrollment-of-CardiAMP-Cell-Therapy-for-the-Treatment-of-Chronic-Myocardial-Ischemia-Trial-Open-Label-Roll-In-Cohort.html
Market Place
Share 
